The general contours of the White House’s backroom deal in mid-2009 to win the pharmaceutical industry’s support for health care reform were widely reported at the time. But the details remained obscured until Thursday, when a Republican-led investigation revealed the entirety of the negotiations and how the agreement was struck after nearly falling through.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=98405